Pluristem Therapeutics (PSTI) says it intends to offer an undisclosed sum of common stock and warrants. Jefferies is acting as sole book-running manager, with Oppenheimer acting as co-lead. The company plans to use the funds to conduct clinical trials, research and product development activities and for general corporate purposes. Shares -11.8% AH
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.